Dynamic network biomarker identifies cdkn1a-mediated bone mineralization in the triggering phase of osteoporosis

Exp Mol Med. 2023 Jan;55(1):81-94. doi: 10.1038/s12276-022-00915-9. Epub 2023 Jan 4.

Abstract

The identification of predictive markers to determine the triggering phase prior to the onset of osteoporosis is essential to mitigate further irrevocable deterioration. To determine the early warning signs before osteoporosis, we used the dynamic network biomarker (DNB) approach to analyze time-series gene expression data in a zebrafish osteoporosis model, which revealed that cyclin-dependent kinase inhibitor 1 A (cdkn1a) is a core DNB. We found that cdkn1a negatively regulates osteogenesis, as evidenced by loss-of-function and gain-of-function studies. Specifically, CRISPR/Cas9-mediated cdkn1a knockout in zebrafish significantly altered skeletal development and increased bone mineralization, whereas inducible cdkn1a expression significantly contributed to osteoclast differentiation. We also found several mechanistic clues that cdkn1a participates in osteoclast differentiation by regulating its upstream signaling cascades. To summarize, in this study, we provided new insights into the dynamic nature of osteoporosis and identified cdkn1a as an early-warning signal of osteoporosis onset.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers / metabolism
  • Calcification, Physiologic*
  • Cell Differentiation / genetics
  • Osteoclasts / metabolism
  • Osteogenesis / genetics
  • Osteoporosis* / genetics
  • Osteoporosis* / metabolism
  • Zebrafish / metabolism

Substances

  • Biomarkers